Alcon has officially completed the deactivation of two algorithms used for CustomCornea treatment of myopia with or without astigmatism, the U.S. Food and Drug Administration announced. The algorithms ...
June 6, 2007 — A class 1 recall has been announced for the CustomCornea algorithms for myopia with astigmatism (M3) and myopia without astigmatism (A7), the US Food and Drug Administration (FDA) told ...
Matt Ridley gives a misleading view of gene-environment interactions in myopia (17 May, p 38). There are, in fact, rare forms of inherited high myopia that would cause myopia in almost any environment ...